SARACINO, ILARIA MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.630
NA - Nord America 3.020
EU - Europa 2.742
SA - Sud America 218
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 9.749
Nazione #
US - Stati Uniti d'America 2.973
IT - Italia 1.108
SG - Singapore 1.027
CN - Cina 979
VN - Vietnam 837
GB - Regno Unito 357
HK - Hong Kong 260
SE - Svezia 252
DE - Germania 245
BR - Brasile 173
FR - Francia 151
IN - India 140
NL - Olanda 131
KR - Corea 127
RU - Federazione Russa 110
IE - Irlanda 97
FI - Finlandia 56
JP - Giappone 52
JO - Giordania 50
UA - Ucraina 49
ZA - Sudafrica 47
BG - Bulgaria 34
CA - Canada 33
CI - Costa d'Avorio 26
ID - Indonesia 26
AT - Austria 24
EE - Estonia 21
CH - Svizzera 19
PH - Filippine 19
BD - Bangladesh 18
SC - Seychelles 17
ES - Italia 16
TH - Thailandia 16
AR - Argentina 15
IQ - Iraq 13
BE - Belgio 11
EC - Ecuador 11
TN - Tunisia 11
TR - Turchia 11
TW - Taiwan 11
GR - Grecia 10
MA - Marocco 10
MX - Messico 10
TG - Togo 9
LT - Lituania 8
PK - Pakistan 8
PL - Polonia 7
SA - Arabia Saudita 7
RO - Romania 6
AL - Albania 5
HR - Croazia 5
PT - Portogallo 5
CL - Cile 4
CO - Colombia 4
EG - Egitto 4
PE - Perù 4
PY - Paraguay 4
RS - Serbia 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
MY - Malesia 3
PS - Palestinian Territory 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
GH - Ghana 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
GN - Guinea 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
QA - Qatar 1
RE - Reunion 1
SI - Slovenia 1
SN - Senegal 1
TL - Timor Orientale 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.749
Città #
Singapore 717
Ashburn 330
Hefei 316
Southend 298
Hong Kong 251
Chandler 243
Ho Chi Minh City 195
Fairfield 193
San Jose 187
Santa Clara 172
Hanoi 156
Bologna 145
Seoul 119
Dong Ket 108
Woodbridge 107
Beijing 101
Milan 100
Dublin 96
Princeton 96
Boardman 84
Houston 81
Seattle 80
Wilmington 80
Rome 68
Lauterbourg 65
Ann Arbor 62
Cambridge 61
Council Bluffs 56
Los Angeles 55
New York 54
Amman 50
Tokyo 49
Helsinki 37
Buffalo 35
Turin 35
Sofia 33
Berlin 31
Redmond 31
Westminster 31
Nanjing 30
Tappahannock 30
Padova 29
Bengaluru 28
Abidjan 26
Parma 26
Redondo Beach 24
Da Nang 23
Guangzhou 23
Haiphong 23
Jinan 23
Nuremberg 23
Jacksonville 21
Munich 21
São Paulo 20
Frankfurt am Main 19
Naples 18
Lappeenranta 17
Shanghai 17
Biên Hòa 16
Florence 16
Jakarta 16
Yubileyny 15
Amsterdam 14
Dallas 14
Johannesburg 14
San Diego 14
Shenyang 14
Bari 13
Modena 13
Zhengzhou 13
Changsha 12
Montreal 12
Verona 12
Vienna 12
Chicago 11
Des Moines 11
Frattamaggiore 11
Shenzhen 11
Atlanta 10
Bern 10
Brussels 10
Hebei 10
Hải Dương 9
Lomé 9
Nanchang 9
Norwalk 9
Orem 9
Quận Bình Thạnh 9
Saint Petersburg 9
Catania 8
Curitiba 8
Hangzhou 8
Moscow 8
Mülheim 8
Tianjin 8
Toronto 8
Bangkok 7
Chengdu 7
Faenza 7
Falkenstein 7
Totale 5.900
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 560
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 379
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 266
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 235
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 220
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 210
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 183
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 182
Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models 181
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 178
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 177
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 176
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 175
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 174
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 168
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 168
Therapy for H. pylori: Current concepts 166
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 162
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 160
Clove Essential Oil as a Source of Antitumoral Compounds Capable of Crossing the Blood–Brain Barrier: A Focus on the Effects of β-Caryophyllene and Eugenol in a Glioblastoma Cell Line 156
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 156
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 153
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 151
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 149
The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review 148
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 144
Diagnosi dell'infezione da Helicobacter pylori 144
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 143
Probiotici ricombinanti e loro potenziale sulla salute umana 142
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 139
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 139
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 137
Recombinant probiotics and their potential in human health 137
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 136
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 135
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 132
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 131
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 130
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 129
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 126
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 125
Gluten-Free Diet and Other Celiac Disease Therapies: Current Understanding and Emerging Strategies 124
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 124
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 120
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 119
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 118
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 116
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 115
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 115
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 109
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 108
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 106
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 103
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 98
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 98
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 95
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 92
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 90
Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients. 87
Rescue Therapies for H. pylori Infection in Italy 82
null 81
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 81
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 81
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 74
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 74
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 73
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 63
null 62
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 60
A new non-invasive tool for guiding H. pylori treatment. 51
Antibiotic resistance and therapy for H. Pylori infection in immigrant patients treated in Italy 26
Totale 9.947
Categoria #
all - tutte 26.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 31 19 186
2021/2022861 78 27 42 84 85 27 28 68 34 35 237 116
2022/20231.073 87 121 69 119 63 82 44 79 234 52 67 56
2023/2024628 29 102 43 76 35 99 32 40 19 52 60 41
2024/20251.980 97 243 155 137 280 124 152 91 64 105 150 382
2025/20263.843 359 449 367 363 387 268 458 157 760 275 0 0
Totale 9.947